Comment Period on Revised Forms for Prototype Consumer Patient Safety Reporting System Open Until July 8
- Comment Period on Revised Forms for Prototype Consumer Patient Safety Reporting System Open Until July 8.
- New AHRQ Guide Available on Using Health Information Exchange in Primary Care.
- July 31 Deadline for Letters of Intent for Patient- Centered Outcomes Research Infrastructure Development Program Funding Opportunity.
- Second Evaluation Highlight of CHIPRA Quality Demonstration Grant Program Now Available.
- AHRQ Study Shows Disparities Continue in Well-Child Visits.
- More Research Needed to Assess Risks and Benefits of Migraine Therapy in Children, New AHRQ Report Finds.
- AHRQ Patient Safety Primer Offers Strategies to Prevent Medication Errors.
- AHRQ in the professional literature.
In an effort to realize the untapped potential of health care consumers to provide local providers with their important perspective regarding adverse events they have experienced, AHRQ has funded the development of a prototype Consumer Reporting System for Patient Safety (CRSPS). The prototype is designed for hospitals, systems, group practices, and others to collect information from patients about adverse events that resulted or nearly resulted in harm or injury. The purpose of this project is to test this prototype for its ability to record data from consumers about patient safety events that are defined as an "incident" or "near miss" by the AHRQ Common Formats. AHRQ recognizes that the unique perspective of health care consumers could reveal important information that is not reported through current mechanisms. Patient reports could complement and enhance reports from providers and thus produce a more complete and accurate understanding of the prevalence and characteristics of medical adverse events. This proposed information collection was previously announced in the Federal Register on September 11, 2012, and allowed 60 days for public comment. AHRQ received 45 substantive comments and 64 personal stories from members of the public. To address these comments, substantial revisions were made to the data collection tools and supporting documentation. Details and information about how to comment on the revised data collection tools are now available for public comment until July 8.
A new guide developed by AHRQ outlines a framework for primary care practices to connect to regional health information exchanges. Regional Health eDecisions: A Guide to Connecting Health Information Exchange in Primary Care establishes a blueprint for assessing organizational readiness for connecting an electronic health record (EHR) to a Regional Health Information Organization (RHIO), creating leadership and clinician buy-in for information exchange, addressing technical issues, and ensuring that data acquired from information exchange are accessible within clinician workflows. Using practical insights from Oklahoma Physicians Resource/Research Network, the guide provides a framework for using information obtained from RHIOs for clinical decision making and the delivery of preventive services. With special sections for practice leaders, IT staff, and practice personnel, the guide outlines practical approaches to achieve optimal connectedness with RHIOs to support patient-centered care. Select to access the guide [PDF File, Plugin Software Help]. As a complement to the guide, AHRQ will host a webinar on August 6 about how to use health information exchange to improve primary care practice. Select to register for the webinar.
Letters of intent are due by July 31 for institutions that wish to submit an R24 application for infrastructure development programs under the AHRQ Funding Opportunity Announcement (FOA) PA-12-114. Select to access the announcement. This includes all new, resubmission, or revision applications. This notice is being issued to assist applicants in determining institutional eligibility to apply for this FOA prior to the institution devoting substantial resources to develop an application. For applicants intending to submit an application for the December 2013 receipt date, a request for permission to submit an application letter must be received by AHRQ by July 31.
AHRQ has published the second Evaluation Highlight of the CHIPRA Quality Demonstration Grant Program. The new Evaluation Highlight examines the measurement of medical homes in selected demonstration States. It also describes the development of the Medical Home Index-Revised Short Form [PDF File, Plugin Software Help], an adaptation of the Medical Home Index, which is being used to evaluate the demonstration projects. Select to access the Evaluation Highlight, [PDF File, Plugin Software Help] titled How are States and evaluators measuring medical homeness in the CHIPRA Quality Demonstration Grant Program? Additional reports and resources are available on the national evaluation Web page.
Children from families in the two lowest-income brackets in the United States had approximately half the number of recommended well-child visits in 2007-2008, compared with average adherence of nearly three-quarters among those in the highest-income bracket, according to a new AHRQ study. The gap has not narrowed significantly since 1996-1998, according to a study published online March 4 in Health Affairs. The study, by AHRQ researchers Thomas Selden and Salam Abdus, also analyzed adherence with well-child visit recommendations by whether the children had a usual source of care and insurance coverage, as well as by race or ethnicity, parent education, and other factors. They found 63 percent adherence among the children who had a usual source of care in 2007-2008, compared with 24 percent adherence among those who did not. Similarly, adherence was 64 percent among privately insured children and 57 percent for publicly insured children in 2007-2008, compared with 32 percent among uninsured children. Select to access the abstract on PubMed®.
Limited evidence is available on the benefits and harms of therapies to prevent headaches in children because the quality of studies involving children is poor and the studies lack detailed information, a new research review from AHRQ's Effective Health Care Program finds. Migraines significantly affect children's physical, psychological, and social well-being, and have been shown to significantly impair learning and school productivity. Low strength evidence suggests that the beta blocker propranolol is more effective than a placebo for preventing migraine in children, with no negative effects that could lead to treatment discontinuation. However, non-drug treatments such as stress management demonstrated better benefit-to-harm ratios than drug treatments in randomly controlled trials. More research is needed on the comparative effectiveness of multimodal drug and disease management approaches; the long-term benefits, safety, and adherence with preventive treatments; and the effects and risks of off-label drug use for migraine prevention. Select to access the full review, Migraine in Children: Preventive Pharmacologic Treatments.
A growing evidence base supports specific strategies to prevent adverse drug events (ADEs), according to a patient safety primer posted online on AHRQ's Patient Safety Network (PSNet). The primer outlines strategies providers can use at each stage of the medication use pathway–prescribing, transcribing, dispensing, administration–to prevent ADEs. These strategies range from using computerized provider order entry and clinical decision support to minimizing nurse disruption and providing better patient education and medication labeling. The primer also identifies known risk factors for ADEs, including health literacy, patient characteristics, high-alert medications and transitions in care. Select to access the full patient safety primer, titled "Medication Errors".
McKinnell JA, Huang SS, Eells SJ, et al. Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 2013 Feb; 34(2):161-70. Select to access the abstract on PubMed®.
Goldman LE, Chu PW, Osmond D, et al. Accuracy of do not resuscitate (DNR) in administrative data. Med Care Res Rev 2013 Feb; 70(1):98-112. Select to access the abstract on PubMed®.
Braddock CH 3rd. Supporting shared decision making when clinical evidence is low. Med Care Res Rev 2013 Feb; 70(1 Suppl):129S-140S. Select to access the abstract on PubMed®.
Bauer NS, Gilbert AL, Carroll AE, et al. Associations of early exposure to intimate partner violence and parental depression with subsequent mental health outcomes. JAMA Pediatr 2013 Feb 4. Select to access the abstract on PubMed®.
Meacham LR, Edwards PJ, Cherven BO, Palgon M, Espinoza S, Hassen-Schilling L, Mertens AC. Primary care providers as partners in long-term follow-up of pediatric cancer survivors. J Cancer Surviv 2012 Sep; 6(3):270-7. Select to access the abstract on PubMed®.
Fleisch AF, Baccarelli AA. Environmental epigenetics: a role in endocrine disease? J Mol Endocrinol 2012 Oct 1; 49(2):R61-R67. Select to access the abstract on PubMed®.
Callaghan B, Kerber K, Longoria R, et al. Capturing cases of distal symmetric polyneuropathy in a community. Muscle Nerve 2012 Dec; 46(6):943-6. Select to access the abstract on PubMed®.
Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli K, et al. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst 2013 Feb 5. Select to access the abstract on PubMed®.
Please address comments and questions regarding the AHRQ Electronic Newsletter to Linwood Norman at Linwood.Norman@ahrq.hhs.gov or (301) 427-1248..
Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in.
If you have any questions or problems with the subscription service, email: firstname.lastname@example.org. For other inquiries, Contact Us.
This service is provided to you at no charge by the Agency for Healthcare Research and Quality (AHRQ).